PAR

Par Drugs and Chemicals Shareholding Pattern

₹117.75-6.01%close, 9 Oct 2026
Market cap
₹145 crore
P/E
22.5
P/B
2.85
ROE
14.5%
Dividend yield
1.20%
52-week range
₹84.78 – ₹158.96

As of Jun 2026, promoters held 48.50% of Par Drugs and Chemicals, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.

Par Drugs and Chemicals shareholding pattern

Percentage of shares held, by quarter, newest first.

Par Drugs and Chemicals shareholding by category (% of equity)
HolderJun 2026
Promoters48.50%
Foreign institutions (FII/FPI)18.40%
Domestic institutions (DII)14.20%
of which mutual funds8.50%
Government0.00%
Public18.90%
Others2.10%

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.

Par Drugs and Chemicals shareholding pattern — frequently asked questions

What is the promoter holding in Par Drugs and Chemicals?

Promoters held 48.50% of Par Drugs and Chemicals as of Jun 2026.

How much do FIIs hold in Par Drugs and Chemicals?

Foreign institutional investors held 18.40% of Par Drugs and Chemicals as of Jun 2026.

How much do domestic institutions hold in Par Drugs and Chemicals?

Domestic institutional investors, including mutual funds and insurers, held 14.20% of Par Drugs and Chemicals as of Jun 2026; mutual funds alone held 8.50%.

Who owns Par Drugs and Chemicals?

As of Jun 2026, Par Drugs and Chemicals' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.

Same Data For Peers

Trade Par Drugs and Chemicals With ATS

Track PAR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.